Summary & Overview

CPT 86382: Viral Neutralization Antibody Test

CPT code 86382 denotes a laboratory neutralization test used to quantify functional viral antibody levels in patient serum. Nationally, this code matters for infectious disease diagnosis, post-vaccination immunity assessment, and epidemiologic surveillance because neutralization assays provide clinically meaningful measures of protective immunity beyond standard antibody presence. Coverage and payment policies for this specialized serologic service vary across major payers and Medicare, affecting laboratory workflows and patient access to confirmatory testing.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of payer coverage patterns, typical sites of service and clinical contexts where neutralization testing is ordered, and benchmarking of where this service fits within laboratory and infectious disease service lines. The publication summarizes policy updates that influence laboratory coding and billing, highlights clinical scenarios that commonly prompt 86382 testing, and outlines how this test is reported operationally in laboratory settings.

This resource is intended to inform laboratory administrators, billing personnel, and clinical teams about the clinical role and payer landscape associated with CPT code 86382, and to provide a clear, national-level reference on use and reporting of viral neutralization antibody testing.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare86382CPTserologyneutralization testvirologylaboratoryimmunity testingdiagnostic testing

Billing Code Overview

CPT code 86382 describes a laboratory neutralization test performed by a lab analyst to determine the level of viral antibodies in a patient’s blood. This test assesses functional antibody activity by measuring the ability of patient serum to neutralize a virus, providing information on immune response or prior exposure.

Service type: Laboratory diagnostic serology test

Typical site of service: Clinical laboratory or hospital laboratory

Clinical & Coding Specifications

Clinical Context

A 35-year-old outpatient presents to the infectious disease clinic with a history of recent viral exposure and ambiguous serologic screening results. The clinician orders a viral neutralization test to confirm the presence and titer of functional, virus-specific neutralizing antibodies. The patient has a prior screening antibody test with low-positive IgG or equivocal results, or the patient is being evaluated for immune status after recovery from a viral illness or following vaccination.

The clinical workflow: the phlebotomy team collects a blood specimen in the laboratory’s required tube and sends it to the virology lab. The laboratory analyst performs a neutralization assay that incubates patient serum with live or pseudotyped virus and susceptible cell cultures, quantifying the dilution at which viral infectivity is neutralized. Results are reviewed by the laboratory director and reported to the ordering provider via the electronic health record. Typical turnaround time ranges from 24–72 hours depending on assay complexity. Typical site of service is an outpatient laboratory or hospital virology laboratory; testing may occur within an ambulatory clinic network, hospital inpatient lab, or public health laboratory for confirmatory antibody measurement.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Used when billing only the professional component of the test (interpretation) separate from the technical component.
`TC`	Technical component	Used when billing only the technical component (laboratory performance) of the test.
`90`	Reference (outside) lab	Used when the test is performed by another laboratory and billed by that reference lab.
`91`	Repeat clinical diagnostic laboratory test	Used when the test is repeated on the same day to obtain a reliable result.
`59`	Distinct procedural service	Used when this test is a distinct service from other procedures on the same day that are not normally reported together.
`52`	Reduced services	Used when the test was partially reduced or not performed to the full extent.
`53`	Discontinued procedure	Used when the neutralization test was started but discontinued for documented clinical reasons.
`76`	Repeat procedure by same provider	Used when the same provider repeats the neutralization test on another occasion.
`77`	Repeat procedure by another provider	Used when a different provider repeats the neutralization test.
`90`	Reference laboratory (duplicate of above)	See row for `90`.

Taxonomy Code	Specialty	Notes
2084P0800X	Infectious Disease	Infectious disease physicians order and interpret serologic and neutralization testing.
207K00000X	Pathology	Pathologists and clinical laboratory directors oversee virology testing quality and interpretation.
2080P0002X	Pediatrics Infectious Disease	Pediatric ID specialists order neutralization assays for pediatric vaccine or infection evaluation.
363A00000X	Medical Laboratory Technologist/Clinical Lab Scientist	Laboratory scientists perform the assay and report results.
174400000X	Public Health Laboratory	Public health laboratorians perform confirmatory neutralization testing for surveillance and outbreak response.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z23`	Encounter for immunization	Post-vaccination neutralizing antibody testing to assess immune response.
`B34.9`	Viral infection, unspecified	Neutralization testing to help identify immune status after a nonspecific viral illness.
`B20`	Human immunodeficiency virus [HIV] disease	Neutralization assays may be used in research or specialized settings to assess antibody responses.
`J12.9`	Viral pneumonia, unspecified	Assessment of virus-specific neutralizing antibodies in a patient recovering from viral pneumonia.
`Z09`	Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm	Follow-up serologic assessment including neutralization testing when indicated after treatment or infection resolution.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87070`	Culture, bacterial; any source, bacterial isolation and presumptive identification	May be performed in parallel when evaluating bacterial co-infection or alternate etiologies in symptomatic patients.
`86769`	Antibody; HIV, confirmatory, quantitative (e.g., neutralization)	Used in contexts where confirmatory quantitative antibody testing or neutralization-style assays are required for viral infections with similar workflow.
`87389`	Infectious agent antigen detection by immunoassay technique, each agent	Performed as an initial screening antigen test before confirmatory neutralization testing when appropriate.
`87635`	Infectious agent detection by nucleic acid (e.g., PCR), multiple viruses	Molecular testing often performed before or alongside serology to detect active viral infection.
`96372`	Therapeutic, prophylactic, or diagnostic injection (e.g., vaccine)	Vaccination status and post-vaccination neutralizing antibody testing are commonly linked; vaccination administration may precede serologic testing.